Agents and Actions

, Volume 42, Issue 1–2, pp 34–39 | Cite as

Differential effects of phosphoramidon and captopril on NK1 receptor-mediated plasma extravasation in the rat trachea

  • James J. Brokaw
  • Gary W. White


We sought to confirm the identity of the tachykinin receptor subtype that mediates plasma extravasation in the rat trachea, and assess the respective contributions of neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE) in regulating this tachykinin-induced response. To achieve these aims, we determined the relative potencies of several natural tachykinins and receptor-selective synthetic agonists, both before and after inhibiting NEP with phosphoramidon and ACE with captopril. We also determined the effects of these peptidase inhibitors, and the NK-1 receptor antagonist L-703,606, on the plasma extravasation produced by capsaicin, which releases tachykinins endogenously from sensory nerve endings. We found that the rank order of potency for producing plasma extravasation in the rat trachea was NK-1 receptor agonist ([Sar9, Met(O2)11] SP)>substance P>neurokinin A> neurokinin B. The NK-2 ([Nle10]NKA (4–10)) and NK-3 ([MePhe7]NKB) receptor agonists were without effect. We observed no change in the relative potencies of these peptides after giving rats phosphoramidon or captopril, which suggests that the different peptide potencies are not simply the consequence of different rates of enzymatic degradation. Nevertheless, the responses to substance P and neurokinin A were clearly potentiated in rats given phosphoramidon, indicating that NEP effectively degrades tachykininsin vivo. No significant potentiation was evident for any peptide in rats given captopril. Similarly, the plasma extravasation produced by capsaicin was potentiated in rats given phosphoramidon, but not in those given captopril. Pretreating rats with L-703,606 abolished the response to capsaicin. We conclude from these observations that NK-1 receptors mediate tachykinin-induced plasma extravasation in the rat trachea, and that NEP regulates this response with little or no contribution from ACE.

Key words

Angiotensin-converting enzyme Neutral endopeptidase Tachykinins Trachea Vascular permeability 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    J. E. Maggio,Tachykinins, Ann. Rev. Neurosci.11, 13–28 (1988).PubMedGoogle Scholar
  2. [2]
    P. J. Barnes, J. N. Baraniuk and M. G. Belvisi,Neuropeptides in the respiratory tract. Am. Rev. Respir. Dis.144, 1187–1198, 1391–1399 (1991).PubMedGoogle Scholar
  3. [3]
    D. M. McDonald,The ultrastructure and permeability of tracheobronchial blood vessels in health and disease. Eur. Respir J.3, 572s-585s (1990).Google Scholar
  4. [4]
    K. Sertl, C. J. Wiedermann, M. L. Kowalski, S. Hurtado J. Plutchok, I. Linnoila, C. B. Pert and M. A. Kaliner,Substance P: The relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability. Am. Rev. Respir. Dis.138, 151–159 (1988).PubMedGoogle Scholar
  5. [5]
    N. Frossard and C. Advenier,Tachykinin receptors and the airways. life Sci.49, 1941–1953 (1991).PubMedGoogle Scholar
  6. [6]
    D. F. Rogers, M. G. Belvisi, B. Aursudkij, T. W. Evans and P. J. Barnes,Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs. Br. J. Pharmacol.95, 1109–1116 (1988).PubMedGoogle Scholar
  7. [7]
    L. Abelli, C.A. Maggi, P. Rovero, E. Del Bianco, D. Regoli, G. Drapeau and A. Giachetti,Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: Evidence for the involvement of NK-1 receptors. J. Auton. Pharmacol.11, 267–275 (1991).PubMedGoogle Scholar
  8. [8]
    A. Eglezos, S. Giuliani, G. Viti and C. A. Maggi,Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK 1 receptors. Eur. J. Pharmacol.209, 277–279 (1991).PubMedGoogle Scholar
  9. [9]
    Y.-H. Lei, P. J. Barnes and D. F. Rogers,Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96, 345, a new non-peptide NK 1 receptor antagonist. Br. J. Pharmacol.105, 261–262 (1992).PubMedGoogle Scholar
  10. [10]
    C. Tousignant, C.-C. Chan, D. Guevremont, C. Brideau, J. J. Hale, M. MacCoss and I. W. Rodger,NK 2 receptors mediate plasma extravasation in guinea-pig lower airways. Br. J. Pharmacol.108, 383–386 (1993).PubMedGoogle Scholar
  11. [11]
    C. M. Lilly, J. M. Drazen and S. A. Shore,Peptidase modulation of airway effects of neuropeptides. Proc. Soc. Exp. Biol. Med.203, 388–404 (1993).PubMedGoogle Scholar
  12. [12]
    K. Sekizawa, J. Tamaoki, P. D. Graf, C. B. Basbaum, D. B. Borson and J. A. Nadel,Enkephalinase inhibitor potentiates mammalian tachykinin-induced contraction in ferret trachea, J. Pharmacol. Exp. Ther.243, 1211–1217 (1987).PubMedGoogle Scholar
  13. [13]
    A. R. Johnson, J. Ashton, W. W. Schulz and E. G. Erdös,Neutral metalloendopeptidase in human lung tissue and cultured cells. Am. Rev. Respir. Dis.132, 564–568 (1985).PubMedGoogle Scholar
  14. [14]
    E. Umeno, J. A. Nadel, H.-T. Huang and D. M. McDonald,Inhibition of neutral endopeptidase potentiates neurogenic inflammation in the rat trachea. J. Appl. Physiol.66, 2647–2652 (1989).PubMedGoogle Scholar
  15. [15]
    G. Piedimonte, D. M. McDonald and J. A. Nadel,Neutral endopeptidase and kininase II mediate glucocorticoid inhibition of neurogenic inflammation in the rat trachea, J. Clin. Invest.88, 40–44 (1991).PubMedGoogle Scholar
  16. [16]
    J. O. Lötvall, W. Elwood, K. Tokuyama, P. J. Barnes and K. F. Chung,Differential effects of phosphoramidon on neurokinin A- and substance P-induced airflow obstruction and airway microvascular leakage in guinea-pig. Br. J. Pharmacol.104, 945–949 (1991).PubMedGoogle Scholar
  17. [17]
    J. O. Lötvall, K. Tokuyama, C.-G. Löfdahl, A. Ullman, P. J. Barnes and K. F. Chung,Peptidase modulation of noncholinergic vagal bronchoconstriction and airway microvascular leakage. J. Appl. Physiol.70, 2730–2735 (1991).PubMedGoogle Scholar
  18. [18]
    A. Saria, C.-R. Martling, Z. Yan, E. Theodorsson-Norheim, R. Gamse and J. M. Lundberg,Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am. Rev. Respir. Dis.137, 1330–1335 (1988).PubMedGoogle Scholar
  19. [19]
    A. Saria and J. M. Lundberg,Evans blue fluorescence: Quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Methods8, 41–49 (1983).PubMedGoogle Scholar
  20. [20]
    D. Regoli, G. Drapeau, S. Dion and R. Couture,New selective agonists for neurokinin receptors: Pharmacological tools for receptor characterization. Trends Pharmacol. Sci.9, 290–295 (1988).PubMedGoogle Scholar
  21. [21]
    T. M. Fong, R.-R. C. Huang and C. D. Strader,Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem.267, 25664–25667 (1992).PubMedGoogle Scholar
  22. [22]
    J. H. Zar,Blostatistical Analysis, 2nd ed., pp. 185–205, Prentice-Hall, Englewood Cliffs, NJ 1984.Google Scholar
  23. [23]
    L. Jacques, R. Couture, G. Drapeau and D. Regoli,Capillary permeability induced by intravenous neurokinins: Receptor characterization and mechanism of action. Naunyn-Schmiedeberg's Arch. Pharmacol.340, 170–179 (1989).Google Scholar
  24. [24]
    L. Abelli, V. Somma, C. A. Maggi, D. Regoli, M. Astolfi, M. Parlani, P. Rovero, B. Conte and A. Meli,Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: Evidence for the involvement of NK-1 receptors. J. Auton. Pharmacol.9, 253–263 (1989).PubMedGoogle Scholar
  25. [25]
    F. Y. Lam and W. R. Ferrell,Specific neurokinin receptors mediate plasma extravasation in the rat knee joint. Br. J. Pharmacol.103, 1263–1267 (1991).PubMedGoogle Scholar
  26. [26]
    N. M. Hooper, A. J. Kenny and A. J. Turner,The metabolism of neuropeptides: Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme). Biochem. J.231, 357–361 (1985).PubMedGoogle Scholar
  27. [27]
    W. R. Welches, K. B. Brosnihan and C. M. Ferrario,A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci.52, 1461–1480 (1993).PubMedGoogle Scholar
  28. [28]
    J. J. Brokaw and G. W. White,Calcitonin gene-related peptide potentiates substance P-induced plasma extravasation in the rat trachea. Lung170, 85–93 (1992).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1994

Authors and Affiliations

  • James J. Brokaw
    • 1
  • Gary W. White
    • 1
  1. 1.Department of AnatomyIndiana University School of MedicineEvansvilleUSA

Personalised recommendations